[1]
|
Zhou, H.H., De, M.T., Guo, Z.L., et al. (2010) Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients. Medical Science, 35, 537-542.
|
[2]
|
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association (2006) Diagnostic and treatment guidelines for liver failure. Journal of Clinical Hepatology, 9, 321-324.
|
[3]
|
Richardson, I.M.D. and Jones, B.L. (2003) Therapeutic guidelines in systemic fungal infections. 3rd Edition, Current Medical Literature, 19-20.
|
[4]
|
Critical Care Medicine Branch of the Chinese Medical Association (2007) Diagnosis and treatment guidelines of patients with severe invasive fungal infections. Chinese Journal of Internal Medicine, 46, 960-966.
|
[5]
|
Dong, C.H., Wei, J., Zhi, H., et al. (2005) Infection and resistance of fungus. Chinese Journal of Nosocomiology, 15, 345-347.
|
[6]
|
Julie, P. and William, M.L. (2005) The management of acute liver failure. Hepatology, 41, 1179-1196.
doi:10.1002/hep.20703
|
[7]
|
Zhang, X.H., Zhang, G.H., Man, C.J., et al. (2004) Clinical study on the severe hepatitis with nosocomial fungal infections and risk factors. Chinese Journal of Hepatology, 12, 389-391.
|
[8]
|
Min, X., Qiang, C. and Qian, C.F. (2007) Clinical analysis of 186 severe hepatitis and cirrhosis patients with nosocomial fungal infections. Journal of Clinical Hepatology, 10, 24-27.
|
[9]
|
Qi, F.X., Mei, L., Bing, L., et al. (2004) Risk factors of fungal colonization in patients with chronic liver disease: a prospective study. Chinese Journal of Nosocomiology, 14, 1344-1346.
|
[10]
|
Segal, B.H., Amyroudis, N.G., Battiwalla, M., et al. (2007) Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad- spectrum antifungal agents and diagnostic adjuncts. Clinical Infective Disease, 44, 402-409.
doi:10.1086/510677
|
[11]
|
Rex, J.H. and Sobel, J.D. (2001) Prophylactic antifungal therapy in the intensive care unit. Clinical Infective Disease, 32, 1191-1200. doi:10.1086/319763
|
[12]
|
Pfaller, M.A., Jones, R.N., Messer, S.A., et al. (1998) National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagnostic Microbiology and Infectious Disease, 31, 327-332. doi:10.1016/S0732-8893(97)00240-X
|
[13]
|
Vehreschild, J.J., Bohme, A., Reichert, D., et al. (2008) Treatment of invasive fungal infections in clinical practice: A multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole. International Journal of Hematology, 87, 126-131.
doi:10.1007/s12185-008-0045-z
|
[14]
|
Ying, J.W. (2008) Liver failure: Definitions, diagnosis and treatment. Journal of Clinical Hepatology, 16, 725- 727.
|
[15]
|
Ju, P.D. and Chun, H.L., et al. (2007) Invasive diagnosis and treatment of fungal infections. Chinese Journal of Infection Control, 6, 359-364.
|